or
Remember me
Back
As you probably know by now, my full-time job is Portfolio Manager of the Rivemont MicroCap Fund. Most of my personal money is invested in the fund.
I’ve been thinking deeply about the implications of this trade war and have tried to minimize tariff exposure as much as possible. The beauty of running a highly differentiated strategy is that I don’t need to track a benchmark or own all the sectors.
Instead of the traditional sector breakdown, here’s the quick and more practical way I look at the portfolio currently:
Healthcare (non-discretionary): Regardless of the state of the economy, people will continue to get sick, take medication, and visit the hospital. In a few cases, well-positioned companies might even gain market share during challenging periods. For example, look at this recent announcement by Covalon Technologies (TSX-V: COV), one of the fund’s holdings: Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
Receive investor kits and email updates from Stockhouse and directly from these companies.
